BIONIK is the global pioneer and leader in providing rehabilitation solutions to individuals with neurological disorders. Formerly known as Interactive Motion Technologies, Bionik is now able to offer a full portfolio of upper and lower extremity robotic systems designed for neurorehabilitation. Conceived and researched at the Massachusetts Institute of Technology’s (MIT) Newman Laboratory for Biomechanics and Human Rehabilitation, InMotion Robotic Neurorecovery Systems are the most thoroughly researched upper extremity neurorehabilitation technology in the world. InMotion Robotic Neuro-Recovery Systems provide intelligent, customized therapy in the intense manner required to achieve development of new neural pathways.
The InMotion ARM/HAND and InMotion WRIST Robotic Neurorecovery Systems feature evidence-based, interactive technology that senses patient movements and limitations, providing assistance-as-needed in real-time. The technology not only prompts participation and provides consistency, it also encourages appropriate movement while discouraging movement that is inappropriate. By automatically and continuously adapting to and challenging each patient’s ability, the intelligent algorithms behind InMotion systems enable clinicians to automatically deliver personalized intensive shoulder, elbow, hand and wrist sensorimotor therapy to patients with mild to severe impairments. More important, the unique therapy these systems offer promotes development of new neural pathways resulting in marked and meaningful improvement when compared with usual care and treatment.
Scores of independent and controlled studies conducted at world-leading research institutions over twenty years, involving more than 1200 clinical subjects, show clear improvement in both adults and children with moderate to severe impairment, even years post-stroke. Assessments using the most widely accepted tests of functional ability—FIM, Fugl-Meyer and Wolf Motor Function—support the findings. Subjects in acute, sub-acute and chronic treatment settings took part in these clinical studies, validating efficacy of InMotion Systems across a broad range of settings.
The level, consistency and sustainability of improvement is unparalleled—robotic therapy delivered with InMotion Robotic Neurorecovery Systems augments the body’s remarkable capability to learn, reacquire and improve motor skills using the brain’s inherent neuroplasticity. No other products on the market come close to demonstrating results like this. With these systems, BIONIK is redefining recovery for patients suffering from neurological impairments, including stroke, cerebral palsy, and spinal cord Injury.
We are also developing a lower-body exoskeleton designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking